Shuo‐Meng Wang
Papers
1
Total Citations
6
H-Index
1
About
Shuo-Meng Wang is a leading urologic oncologist whose work focuses on advancing surgical treatments for prostate cancer, particularly in Asian populations. His major contributions center on refining patient selection for laparoscopic radical prostatectomy (LRP) monotherapy in high-risk disease. In his landmark 2013 study, Wang demonstrated that men with high-risk prostate cancer possessing only one D’Amico risk factor can achieve excellent oncologic outcomes through LRP alone, challenging the conventional wisdom that such patients invariably require multimodal therapy. This work, which has garnered 6 citations, provides crucial evidence for a more aggressive yet less invasive surgical approach in carefully selected patients. Wang’s research is particularly valuable for its focus on an Asian tertiary referral center, addressing a significant gap in the literature regarding prostate cancer outcomes in non-Western populations. His findings have helped establish more nuanced treatment algorithms, enabling surgeons to identify which high-risk patients can safely avoid the morbidity of additional radiation or hormone therapy. Through his meticulous surgical outcomes research, Wang continues to shape the evolution of prostate cancer management toward more personalized, risk-adapted strategies.
Research Focus
Key Achievements
Top Papers
- 1